(Hypertension. 1995;26:801.)
© 1995 American Heart Association, Inc.
Articles |
Target Organ Status and Serum Lipids in Patients With White Coat Hypertension
From the Centro per lo Studio e la Terapia dell’ Ipertensione Arteriosa, Istituto di Fisiopatologia Medica, University G. D’Annunzio, Chieti, Italy.
Abstract Target organ status and serum lipids were investigated in white coat hypertension in comparison with sustained hypertension and normotension. We selected three groups balanced for sex, age, body mass index, and smoking habit: 50 sustained hypertensives (clinical hypertension and 24-hour ambulatory blood pressure >135/85 mm Hg, a cutoff limit obtained from a normotensive population), 25 white coat hypertensives (clinical hypertension and 24-hour ambulatory blood pressure <135/85 mm Hg), and 25 normotensives. Subjects underwent echocardiographic examination to assess left ventricular mass index, carotid ultrasonography to evaluate intima-media thickness and atherosclerotic plaques, venous occlusion plethysmography to record minimum forearm vascular resistance, and determinations of serum lipid profile and 24-hour urinary albumin excretion. Compared with sustained hypertensives, the white coat hypertensives had significantly lower values of left ventricular mass index (125.9±20 versus 97.6±11.5 g/m2, P<.05), intima-media thickness (0.85±0.18 versus 0.71±0.15 mm, P<.05), minimum forearm vascular resistance (2.33±0.11 versus 2.04±0.08 resistance units, P<.05), urinary albumin excretion values (15.1±13.8 versus 4.45±1.48 mg per 24 hours, P<.0001), prevalence of left ventricular hypertrophy (38% versus 4%, P<.002), intima-media thickening (28% versus 4%, P<.015), and microalbuminuria (22% versus 0%, P<.015). No significant difference, however, was observed between the white coat hypertensives and the normotensives. Serum lipid profile was similar in the white coat hypertensives and in the normotensives. In conclusion, our data demonstrate that white coat hypertensives do not show target organ damage and do not present an unfavorable lipid profile, suggesting that they may be counseled on nonpharmacological therapy and that drug treatment could be withheld or delayed.
Key Words: hypertension, white coat • lipids • blood pressure monitoring, ambulatory
This article has been cited by other articles:
 |
|
 |
|
  C. K. Kramer, C. B. Leitao, L. H. Canani, and J. L. Gross Impact of White-Coat Hypertension on Microvascular Complications in Type 2 Diabetes Diabetes Care, December 1, 2008; 31(12): 2233 - 2237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Erdogan, H Gullu, M Caliskan, I Yildirim, D Tok, and H Muderrisoglu Coronary flow reserve is preserved in white-coat hypertension Heart, August 1, 2006; 92(8): 1109 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Smith, L. N. Graham, A. F. Mackintosh, J. B. Stoker, and D. A. S. G. Mary Sympathetic neural mechanisms in white-coat hypertension J. Am. Coll. Cardiol., July 3, 2002; 40(1): 126 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bjorklund, L. Lind, B. Vessby, B. Andren, and H. Lithell Different Metabolic Predictors of White-Coat and Sustained Hypertension Over a 20-Year Follow-Up Period: A Population-Based Study of Elderly Men Circulation, July 2, 2002; 106(1): 63 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Grandi, R. Broggi, S. Colombo, R. Santillo, D. Imperiale, A. Bertolini, L. Guasti, and A. Venco Left Ventricular Changes in Isolated Office Hypertension: A Blood Pressure-Matched Comparison With Normotension and Sustained Hypertension Arch Intern Med, December 10, 2001; 161(22): 2677 - 2681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Sega, G. Trocino, A. Lanzarotti, S. Carugo, G. Cesana, R. Schiavina, F. Valagussa, M. Bombelli, C. Giannattasio, A. Zanchetti, et al. Alterations of Cardiac Structure in Patients With Isolated Office, Ambulatory, or Home Hypertension: Data From the General Population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study) Circulation, September 18, 2001; 104(12): 1385 - 1392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Muldoon, P. Nazzaro, K. Sutton-Tyrrell, and S. B. Manuck White-Coat Hypertension and Carotid Artery Atherosclerosis: A Matching Study Arch Intern Med, May 22, 2000; 160(10): 1507 - 1512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Verdecchia Prognostic Value of Ambulatory Blood Pressure : Current Evidence and Clinical Implications Hypertension, March 1, 2000; 35(3): 844 - 851. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. MacDonald, G. P. Laing, M. P. Wilson, and T. W. Wilson Prevalence and predictors of white-coat response in patients with treated hypertension Can. Med. Assoc. J., August 1, 1999; 161(3): 265 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Owens, N. Atkins, and E. O'Brien Diagnosis of White Coat Hypertension by Ambulatory Blood Pressure Monitoring Hypertension, August 1, 1999; 34(2): 267 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pauletto, P. Palatini, S. Da Ros, V. Pagliara, N. Santipolo, S. Baccillieri, E. Casiglia, P. Mormino, and A. C. Pessina Factors Underlying the Increase in Carotid Intima-Media Thickness in Borderline Hypertensives Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1231 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Khattar, R. Senior, and A. Lahiri Cardiovascular Outcome in White-Coat Versus Sustained Mild Hypertension : A 10-Year Follow-Up Study Circulation, November 3, 1998; 98(18): 1892 - 1897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Pierdomenico, F. Costantini, A. Bucci, D. De Cesare, F. Cuccurullo, and A. Mezzetti Low-Density Lipoprotein Oxidation and Vitamins E and C in Sustained and White-Coat Hypertension Hypertension, February 1, 1998; 31(2): 621 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Palatini, P. Mormino, M. Santonastaso, L. Mos, M. Dal Follo, G. Zanata, and A. C. Pessina Target-Organ Damage in Stage I Hypertensive Subjects With White Coat and Sustained Hypertension: Results From the HARVEST Study Hypertension, January 1, 1998; 31(1): 57 - 63. [Abstract] [Full Text]
|
|
|
|
|
|
N.-C. Chang, Z.-Y. Lai, P. Chan, and T.-C. Wang Left Ventricular Filling Profiles in Young White-Coat Hypertensive Patients Without Hypertrophy Hypertension, September 1, 1997; 30(3): 746 - 752. [Abstract] [Full Text]
|
|
|
|
|
|
P. Verdecchia, G. Schillaci, C. Borgioni, A. Ciucci, and C. Porcellati Prognostic Significance of the White Coat Effect Hypertension, June 1, 1997; 29(6): 1218 - 1224. [Abstract] [Full Text]
|
|
|
|
|
|
C. Russo, O. Olivieri, D. Girelli, P. Guarini, R. Pasqualini, M. Azzini, and R. Corrocher Increased Membrane Ratios of Metabolite to Precursor Fatty Acid in Essential Hypertension Hypertension, April 1, 1997; 29(4): 1058 - 1063. [Abstract] [Full Text]
|
|